Merck Confirms FDA Approval Of Hep C Drug At A Cost Of $54,600 Per Patient
January 29, 2016 at 11:29 AM EST
Merck & Co., Inc. (NYSE: MRK) confirmed after Thursday's market close that the U.S. Food and Drug Administration has approved ...